2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow CILO: new trials by email Literature Review of CILO trials Research Report on CILO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) SEL, FIR, CILO - Nonalcoholic Steatohepatitis | Phase 2 | Completed | Gilead Sciences | 395 | 2018-03-21 | 2020-12-03 |
| Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) SEL, FIR, CILO - Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Completed | Gilead Sciences | 220 | 2016-06-13 | 2022-03-16 |
Non-alcoholic Fatty Liver Disease (2)
Gilead Sciences (2)
New Zealand (2) · United States (2) · Australia (1) · Canada (1) · Hong Kong (1) · Puerto Rico (1)